Narrative review discusses AI-driven pathology models for esophageal cancer and Barrett's esophagus management

This narrative review explores the integration of AI-driven pathology models into the management of patients with esophageal cancer and Barrett's esophagus. The scope of the discussion covers various potential applications, such as early screening of Barrett's esophagus and incipient esophageal cancer, diagnostic refinement through invasion depth quantification, histopathological subtyping, molecular pathology analysis, metastatic evaluation of lymph node involvement, prognostic prediction of patient survival, and efficacy assessment for multimodal therapies.

The authors highlight that while these technologies offer promising avenues for diagnostic and prognostic support, they currently face persistent performance challenges. Additionally, the review addresses the broader societal implications associated with the widespread adoption of such advanced diagnostic tools in clinical practice.

The authors conclude that these AI-driven approaches represent foundational elements of contemporary therapeutic strategies. However, the review does not provide specific numerical data regarding efficacy or safety. The discussion remains focused on the conceptual utility of these models throughout the esophageal cancer disease continuum, without making definitive claims about their immediate clinical implementation.